The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.

ABSTRACT:

Objective

Vasomotor symptoms (VMS) may be a marker of cardiovascular risk. We aimed to evaluate the cross-sectional association of VMS presence and severity with hemostatic parameter levels measured at baseline among Women's Health Initiative (WHI) Hormone Therapy trial postmenopausal participants.

Methods

This cross-sectional analysis included 2,148 postmenopausal women with measures of VMS presence and severity reported in the 4 weeks before WHI baseline, who were not using warfarin or hormone therapy and for whom the following baseline hemostatic parameters were measured within the WHI Cardiovascular Disease Biomarker Case-Control Study: antithrombin, plasminogen activator inhibitor-1, protein C antigen, total and free protein S antigen, total and free tissue factor pathw

SUBMITTER: Harrington LB 

PROVIDER: S-EPMC5365368 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature